As one of the trusted Latanoprost API Manufacturers in India, we operate a world-class manufacturing unit in Vadodara, Gujarat, where every stage of production is carefully monitored to ensure superior quality and regulatory compliance. Our expertise in process optimisation and adherence to cGMP standards has positioned us among the top Latanoprost API Manufacturers in Gujarat and Latanoprost API Manufacturers in Vadodara, serving both domestic and international markets with consistency and reliability.
In addition to manufacturing, Century Pharma is a dependable Latanoprost API Trader in India, offering flexible volumes and prompt delivery to meet diverse customer demands. Our vast distribution network and dedicated logistics support ensure smooth and efficient delivery for clients looking for a trusted Latanoprost API Trader in Gujarat or a Latanoprost API Trader in Vadodara. We are committed to maintaining supply chain integrity and offering tailored solutions to our partners.
With a focus on innovation, scalability, and customer satisfaction, Century Pharma continues to strengthen its presence as a forward-thinking API Pharmaceutical Company. We also provide long-term support through contract manufacturing and the development of new APIs as per client requirements. Whether you need high-quality Latanoprost API or a strategic supply partner, Century Pharma delivers excellence through science, compliance, and collaboration, helping our clients achieve success in ophthalmic therapeutics.
Century Pharma has established a robust global presence, delivering high-quality Active Pharmaceutical Ingredients (APIs) and services across key international markets. With strong footprints in Egypt, Vietnam, Mexico, Russia, Korea, and several MENA/GCC countries (Algeria, Bahrain, Djibouti, Egypt, Iran, Iraq, Jordan, Kuwait, Lebanon, Libya, Mauritania, Morocco, Oman, Qatar, Saudi Arabia, Somalia, Sudan, Syria, Tunisia, the United Arab Emirates, and Yemen.), Century Pharma supports pharmaceutical advancements worldwide. Our expertise spans API manufacturing for human and animal health, enzyme production, biotechnology, and API research.
Additionally, Century Pharma excels in Contract API Manufacturing, Contract API Research, Method API Development, and Stability Studies, catering to regulatory and market-specific needs. As a trusted API manufacturer in India, Century Pharma continues to expand its global reach, fostering long-term collaborations and ensuring quality healthcare solutions across continents.
Century Pharma Ltd. is a Latanoprost API manufacturer based in Vadodara, Gujarat, India. We support pharmaceutical companies with API sourcing and commercial supply enquiries. Contact our team to discuss required quantities, product specifications, and delivery needs.
Pharmaceutical buyers can enquire about the applicable Certificate of Analysis (COA) and product specifications. These documents help buyers evaluate API identity, purity, and batch quality. Contact Century Pharma to confirm documentation availability.
The minimum order quantity depends on product availability, required grade, and commercial terms. Buyers can share their expected purchase quantity with Century Pharma to confirm MOQ, pricing, and delivery schedules.
Century Pharma serves international pharmaceutical markets. Buyers can enquire about Latanoprost API availability, export documentation, and shipping arrangements for their destination country. Supply is subject to applicable regulatory requirements.
To request a quotation, share your required quantity, product grade, quality specifications, destination country, and expected delivery schedule. Century Pharma can review your enquiry and provide available commercial details.
Buyers should review assay, identification, related substances, residual solvents, and applicable pharmacopoeial specifications. They should also evaluate stereochemical identity, degradation impurities, stability, and batch consistency. These checks help pharmaceutical manufacturers assess API quality.
Manufacturers should evaluate API purity, solubility, stability, degradation products, and compatibility with formulation ingredients. They should also review relevant microbial and endotoxin requirements. Finished ophthalmic products must meet applicable sterility and quality standards.
Not necessarily. Latanoprost API intended for ophthalmic formulations is not automatically sterile. Buyers should confirm its sterility status, microbial specifications, and relevant quality documents. They should also verify whether the material suits their intended manufacturing and sterilisation processes.
Latanoprost is sensitive to degradation under certain conditions. Buyers should review stability data, temperature requirements, light exposure limits, and protective packaging. These checks help maintain product quality during storage, transportation, and formulation development.
Latanoprost is a prostaglandin F2α analogue supplied as an isopropyl ester, while Bimatoprost is a synthetic prostamide analogue. Both are used in approved ophthalmic medicines for elevated intraocular pressure. However, their chemical structures and formulation properties differ. Manufacturers should choose the ingredient specified in their approved product and regulatory documents.
International pharmaceutical buyers should request product specifications, an applicable batch COA, GMP evidence, stability information, and available regulatory support documents. For ophthalmic formulations, buyers should also evaluate relevant impurity controls, microbial quality requirements, and sterility-related manufacturing considerations. Documentation requirements vary by country.